Usern_member

Marco Infante

Major Fields of Interest:



  • Diabetes Mellitus (DM)

  • Type 1 Diabetes Mellitus (T1DM)

  • New-Onset T1DM

  • Immunotherapy for T1D

  • Pancreatic islet transplantation

  • Beta-cell function and C-peptide

  • Type 2 Diabetes Mellitus (T2DM)

  • Gestational Diabetes Mellitus (GDM)

  • Atypical Diabetes

  • Immunomodulatory effects of vitamin D

  • Diabetes Technology: Continuous Glucose Monitoring (CGM), Continuous Subcutaneous Insulin Infusion (CSII), Insulin Pumps, Closed-Loop Insulin Delivery Systems (“Artificial Pancreas”)

  • Clinical Endocrinology

  • Clinical Nutrition and Clinical Vitaminology 

  • Precision Medicine and Precision Nutrition 


Education and training:



  • February 17, 2023 - Doctoral Degree (European PhD Label - 35th PhD cycle), PhD in Systems and Experimental Medicine, University of Rome Tor Vergata (Rome, Italy). European PhD Label, PhD Thesis Defense: “Relationship between serum 25-hydroxyvitamin D, stimulated C-peptide and clinical remission phase in adults with new-onset type 1 diabetes mellitus”. Final evaluation: "Excellent Quality, with Honors".

  • From January 2023 to February 2023 - PhD Candidate, PhD Program in Systems and Experimental Medicine (35th PhD cycle), Department of Systems Medicine, University of Rome Tor Vergata (Rome, Italy).

  • From December 2019 to December 2022 - PhD Fellow, PhD Program in Systems and Experimental Medicine (35th PhD cycle), Department of Systems Medicine, University of Rome Tor Vergata (Rome, Italy).

  • November 2019 - Board Certification in Endocrinology and Metabolic Disorders, University of Rome Tor Vergata (Rome, Italy). Experimental thesis: “Continuous glucose monitoring metrics in patients with type 1 diabetes mellitus who achieved long-term insulin independence after islet transplantation”. Final score: 50/50 cum laude.

  • From November 2015 to November 2019 (duration: 4 years) - Resident Fellow, Postgraduate School of Endocrinology and Metabolic Disorders, Department of Systems Medicine, University of Rome Tor Vergata (Rome, Italy).

  • October 28, 2014 - Doctor of Medicine (M.D.) Degree (LM-41), Sapienza University of Rome, School of Medicine, Rome (Italy). Final score: 110/110 cum laude.

  • From October 2012 to October 2014 - Undergraduate Internship, Department of Experimental Medicine, Section of Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome (Rome, Italy).


Academic Appointments:



  • Adjunct Professor of Endocrinology – Degree Course in Medicine and Surgery (LM-41), Faculty of Medicine and Surgery, UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from August 2022 to present.

  • Adjunct Professor of Applied Nutrition in Internal Medicine – Master Degree Course in Human Nutrition Sciences (LM-61), UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from July 2022 to present.

  • Adjunct Professor of Endocrinology - Degree Course in Midwifery, UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from July 2020 to October 2022 (Academic years: 2020-2021; 2021-2022).

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Endocrinology (Course ID/SSD: MED/13; ECTS: 3), School of Medicine and Surgery, University of Rome Tor Vergata (Rome, Italy); from February 2021 to January 2023.

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Clinical Symptomatology (Course ID/SSD: MED/18; MED/09; ECTS: 6), School of Medicine and Surgery, Single-cycle Degree Course in Medicine and Surgery (English language course), University of Rome Tor Vergata (Rome, Italy); from November 2022 to present.

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Internal Medicine and Medical Genetics (Course ID/SSD: MED/09; MED/03; MED/50; MED/06; ECTS: 15), School of Medicine and Surgery, Single-cycle Degree Course in Medicine and Surgery (English language course), University of Rome Tor Vergata (Rome, Italy); from March 2023 to present.

  • Research Scholar - Diabetes Research Institute (DRI), Division of Cellular Transplantation, Clinical Cell Transplant Program - University of Miami Miller School of Medicine (Miami, FL, USA); from January 2019 to present.

    • Clinical research in the field of type 1 diabetes mellitus, pancreatic islet transplantation and diabetes technology

    • Research Physician Scientist in the Collaborative Islet Transplant Registry (CITR)




Present Positions:



  • Adjunct Professor of Endocrinology – Degree Course in Medicine and Surgery (LM-41), Faculty of Medicine and Surgery, UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from August 2022 to present.

  • Adjunct Professor of Applied Nutrition in Internal Medicine – Master Degree Course in Human Nutrition Sciences (LM-61), UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from July 2022 to present.

  • FACN - Fellow of the American College of Nutrition (Hinsdale, IL, USA); from April 2021 to present

  • Research Scholar - Diabetes Research Institute (DRI), Clinical Cell Transplant Program - University of Miami Miller School of Medicine (Miami, FL, USA)

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Endocrinology (Course ID/SSD: MED/13; ECTS: 3), School of Medicine and Surgery, University of Rome Tor Vergata (Rome, Italy); from February 2021 to January 2023.

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Clinical Symptomatology (Course ID/SSD: MED/18; MED/09; ECTS: 6), School of Medicine and Surgery, Single-cycle Degree Course in Medicine and Surgery (English language course), University of Rome Tor Vergata (Rome, Italy); from November 2022 to present.

  • Subject Matter Expert (SME) - Undergraduate Degree Course in Internal Medicine and Medical Genetics (Course ID/SSD: MED/09; MED/03; MED/50; MED/06; ECTS: 15), School of Medicine and Surgery, Single-cycle Degree Course in Medicine and Surgery (English language course), University of Rome Tor Vergata (Rome, Italy); from March 2023 to present.

  • Clinical Researcher - Diabetes Research Institute Federation (DRIF), University of Miami Miller School of Medicine (Miami, FL, USA) and University of Rome Tor Vergata (Rome, Italy); from January 2019 to present.


Academic Teaching Positions:



  • Adjunct Professor of Endocrinology – Degree Course in Medicine and Surgery (LM-41), Faculty of Medicine and Surgery, UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from August 2022 to present.

  • Adjunct Professor of Applied Nutrition in Internal Medicine – Master Degree Course in Human Nutrition Sciences (LM-61), UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from July 2022 to present.

  • Adjunct Professor of Endocrinology - Degree Course in Midwifery, UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from July 2020 to October 2022 (Academic years: 2020-2021; 2021-2022).

  • First level Master’s degree in Orthopedics and Sport Traumatology; Course Module: “Metabolism of athletes” (SSD MED/13; ECTS: 4) - UniCamillus, Saint Camillus International University of Health Sciences (Rome, Italy); from September 2020 to present (Academic years: 2019-2020; 2020-2021; 2021-2022; 2022-2023).

  • Second level Master’s degree in Medical Surgical and Rehabilitative Management of the Diabetic Foot and Leadership of the Multidisciplinary Team - University of Rome Tor Vergata, Faculty of Medicine and Surgery, Academic year 2021-2022; (SSD MED/13, MED/09, MED/49; ECTS: 60); Course Module: “Type 1 Diabetes (T1D): From Pathophysiology to Treatment”; February 2022.


Professional activities:



  • From October 2019 to present – Scientific Director of CardioEndocrinoMetabolica, Endocrine and Cardiometabolic Center (Salerno, Italy).

  • From November 2019 to February 2022 – Endocrinology and Diabetology Consultant at the Unit of Endocrinology, Diabetes and Metabolic Diseases, CTO Andrea Alesini Hospital, Department of Systems Medicine, University of Rome Tor Vergata (Rome, Italy).

  • From November 2015 to December 2018 – Resident Fellow at the Unit of Endocrinology, Diabetes and Metabolic Diseases, Department of Systems Medicine, CTO Andrea Alesini Hospital, University of Rome Tor Vergata (Rome, Italy)

  • From February 2018 to May 2018 – Resident Fellow at the Unit of Endocrinology, Diabetes and Metabolism, San Giovanni Calibita Fatebenefratelli Hospital, University of Rome Tor Vergata (Rome, Italy).

  • From November 2015 to January 2018 – Resident Fellow at Unit of Endocrinology, Diabetes and Metabolic diseases & Diabetic Foot Unit, Department of Medical Science, University Hospital-Fondazione Policlinico di Tor Vergata (Rome, Italy).

  • From February 2015 to October 2015 – Medical Trainee at the Unit of Endocrinology and Metabolic Diseases, CTO Andrea Alesini Hospital, Department of Systems Medicine, University of Rome Tor Vergata (Rome, Italy).

  • From February 2015 to October 2015 – Visiting Fellow at the Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana (Rome, Italy).


Courses and certifications:



  • Certificate of Excellence in Lipidology, issued by the European Atherosclerosis Society (EAS), February 2019.

  • Collaborative Institutional Training Initiative (CITI) Program Course, University of Miami Miller School of Medicine (FL, USA), February 2019.

  • Advanced Course on Epidemiology and Genetics of Atherosclerosis and Causality of Risk Factors, European Atherosclerosis Society, EAS, Copenhagen (Denmark), October 2018.

  • Advanced Diploma in Ultrasound in Endocrinology, issued by the Italian Society for Ultrasound in Medicine and Biology (SIUMB), September 2018.

  • Advanced practical course in Ultrasound of thyroid, parathyroid glands and neck lymph nodes,Italian Society for Ultrasound in Medicine and Biology (SIUMB), Ospedale del Mare, Naples (Italy), from June 2018 to July 2018.

  • Diploma in Clinical Ultrasound, issued by the Italian Society for Ultrasound in Medicine and Biology (SIUMB), June 2016.

  • Advanced practical course in Clinical Ultrasound, Italian Society for Ultrasound in Medicine and Biology (SIUMB), Policlinico Universitario Agostino Gemelli, Rome (Italy), from September 2015 to October 2015.


Membership in Scientific Societies and Organizations:



  • American Diabetes Association (ADA)

  • Diabetes Research Institute Federation (DRIF)

  • International Pancreas and Islet Transplant Association (IPITA)

  • The Cure Alliance

  • Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN)

  • European Atherosclerosis Society (EAS)

  • Italian Society of Diabetology (SID)

  • Italian Society of Endocrinology (SIE)


Languages:


  • Italian (mother tongue)

  • English (proficient user)


List of main publications in peer-reviewed international Journals:



  1. Caprio M, Infante M, Calanchini M, Mammi C, Fabbri A. Vitamin D: not just the bone. Evidence for beneficial pleiotropic extraskeletal effects. Eating and Weight Disorders (2017). DOI: 10.1007/s40519-016-0312-6.

  2. Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of Adrenal Steroids on Regulation of Adipose Tissue. Comprehensive Physiology (2017). DOI: 10.1002/cphy.c160037.

  3. Infante M, Caprio M, Fabbri A (2017). Regulation of adipose tissue function and metabolism: role of mineralocorticoid receptor. Official Journal of the International Union of Aesthetic Medicine - UIME, ISSN 2421-7115 (vol. 3, nr. 4, October/December 2017).

  4. Infante M, Corradini D, Romano M, Bellia A, Lauro D. Life-threatening hypocalcemia in a patient with highly suspected osteomalacia: a case report. AACE Clinical Case Reports (2018). DOI: 10.4158/EP171982.CR.

  5. Infante M, Sears B, Rizzo AM, Mariani Cerati D, Caprio M, Ricordi C, Fabbri A. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature review. Nutr Neurosci. 2018 Dec 13:1-12. DOI: 10.1080/1028415X.2018.1557385.

  6. Izzo V, Greco C, Corradini D, Infante M, Staltari MT, Romano M, Bellia A, Lauro D, Uccioli L. Insulin autoimmune syndrome in an Argentine woman taking α-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018 Dec 26;6:2050313X18819601. DOI: 10.1177/2050313X18819601.

  7. Infante M, Fabi A, Cognetti F, Gorini S, Caprio M, Fabbri A. RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives. J Exp Clin Cancer Res. 2019 Jan 8;38(1):12. DOI: 10.1186/s13046-018-1001-2.

  8. Infante M, Armani A, Marzolla V, Fabbri A, Caprio M. Adipocyte Mineralocorticoid Receptor. Vitam Horm. 2019;109:189-209. DOI: 10.1016/bs.vh.2018.10.005. Epub 2018 Dec 21.

  9. Infante M, Ricordi C, Baidal DA, Alejandro R, Lanzoni G, Sears B, Caprio M, Fabbri A. VITAL study: an incomplete picture? Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):3142-3147. DOI: 10.26355/eurrev_201904_17599.

  10. Armani A, Infante M, Fabbri A, Caprio M (2019). Comment on “mineralocorticoid antagonism enhances brown adipose tissue function in humans: A randomized placebo‐controlled cross‐over study” Diabetes Obes Metab. 2019; 21: 2024-2026. DOI:10.1111/dom.13756.

  11. Caprio M, Moriconi E, Infante M, De Martino MU, Aversa A. PS-05-003 The role of nutritional intervention in the treatment of male hypogonadism secondary to obesity (Conference abstract at the 21st Congress of the European Society for Sexual Medicine; 14-16 February 2019, Ljubljana, Slovenia). The Journal of Sexual Medicine. May 2019 Volume 16, Issue 5, Supplement 2, Page S14. DOI: 10.1016/j.jsxm.2019.03.072.

  12. Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, et al., on behalf of the Cardiovascular Endocrinology Club of the Italian Society of Endocrinology. Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2019 Nov;42(11):1365-1386. DOI: 10.1007/s40618-019-01061-2.

  13. Gorini S, Kim SK, Infante M, Mammi C, La Vignera S, Fabbri A, Jaffe IZ, Caprio M. Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging. Front Endocrinol (Lausanne). 2019 Aug 23;10:584. DOI: 10.3389/fendo.2019.00584.

  14. Ricordi C, Clare-Salzler M, Infante M, Baggerly C, Aliano J, McDonnell S, Chritton S. Vitamin D and Omega 3 Field Study on Progression of Type 1 Diabetes. CellR4 Repair Replace Regen Reprogram. 2019;7. pii: e2737. DOI: 10.32113/cellr4_20198_2737.

  15. Infante M, Ricordi C, Sanchez J, Clare-Salzler MJ, Padilla N, Fuenmayor V, Chavez C, Alvarez A, Baidal D, Alejandro R, Caprio M, Fabbri A. Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes. Nutrients. 2019 Sep 11;11(9). pii: E2185. DOI: 10.3390/nu11092185.

  16. Simonetto M*, Infante M*, Sacco RL, Rundek T, Della-Morte D. A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia. Nutrients. 2019 Sep 23;11(10). pii: E2279. DOI: 10.3390/nu11102279. *Equal contribution to the manuscript.

  17. Infante M, Ricordi C. Editorial - Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity. Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8702-8704. DOI: 10.26355/eurrev_201910_19188.

  18. Infante M, Della-Morte D. Diabetes and cognitive dysfunction: a dangerous liaison. CellR4 2019; 7: e2776. DOI: 10.32113/cellr4_201910_2776.

  19. Infante M, Ricordi C, Padilla N, Alvarez A, Linetsky E, Lanzoni G, Mattina A, Bertuzzi F, Fabbri A, Baidal D, Alejandro R. The Role of Vitamin D and Omega-3 PUFAs in Islet Transplantation. Nutrients. 2019 Dec 3;11(12). pii: E2937. DOI: 10.3390/nu11122937.

  20. Fabbri A, Infante M, Ricordi C. Editorial - Vitamin D Status: A Key Modulator of Innate Immunity and Natural Defense From Acute Viral Respiratory Infections. Eur Rev Med Pharmacol Sci 2020 Apr;24(7):4048-4052. DOI: 10.26355/eurrev_202004_20876.

  21. Infante M, Ricordi C, Fabbri A. Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic. J Diabetes. 2020;12(9):659-667. DOI:10.1111/1753-0407.13053.

  22. Infante M, Ricordi C, Alejandro R, Caprio M, Fabbri A. Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Rev Anti Infect Ther. 2021 Jan;19(1):5-16. Epub 2020 Aug 16. DOI: 10.1080/14787210.2020.1799785.

  23. Moriconi E, Feraco A, Marzolla V, Infante M, Lombardo M, Fabbri A, Caprio M. Neuroendocrine and Metabolic Effects of Low-Calorie and Non-Calorie Sweeteners. Front Endocrinol (Lausanne). 2020 Jul 16; 11:444. DOI: 10.3389/fendo.2020.00444.

  24. Maia Pinheiro M, Moura Maia Pinheiro F, Pires Amaral Resende LL, Nogueira Diniz S, Fabbri A, Infante M. Improvement of pure sensory mononeuritis multiplex and IgG1 deficiency with sitagliptin plus Vitamin D3. Eur Rev Med Pharmacol Sci. 2020;24(15):8151-8159. DOI:10.26355/eurrev_202008_22502.

  25. Gunawardana SC, Infante M. Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives. CellR4 2020; 8: e2986. DOI: 10.32113/cellr4_202012_2986.

  26. Maia Pinheiro M, Maia Pinheiro FM, Amaral Resende LLP, Diniz SN, Fabbri A, Infante M. 36-month follow-up of a pure sensory mononeuritis multiplex and IgG1 deficiency improved after treatment with sitagliptin and Vitamin D3. Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1768-1769. DOI: 10.26355/eurrev_202102_25064.

  27. Infante M*, Buoso A, Pieri M, Lupisella S, Nuccetelli M, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Colizzi V, Morello M*. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study. J Am Coll Nutr. 2021 Feb 18:1-16. DOI: 10.1080/07315724.2021.1877580. Online ahead of print. *Equal contribution to the manuscript. 

  28. Pinheiro MM, Pinheiro FMM, Diniz SN, Fabbri A, Infante M. Combination of vitamin D and dipeptidyl peptidase-4 inhibitors (VIDPP-4i) as an immunomodulation therapy for autoimmune diabetes. Int Immunopharmacol. 2021 Mar 20;95:107518. DOI: 10.1016/j.intimp.2021.107518. Epub ahead of print.

  29. Pinheiro MM, Fabbri A, Infante M. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021 Apr 28. DOI: 10.2217/imt-2020-0349. Epub ahead of print.

  30. D’Avolio A, Isaia G, on behalf of COVID-Vitamin D Study Group [Infante M, et al.], Accademia di Medicina di Torino. Vitamin D in the COVID-19 prevention and treatment: emerging evidence. Pharmadvances. Volume 3, Issue 2, 2021 June: 350-6. DOI: 10.36118/pharmadvances.2021.01.

  31. Infante M, Baidal DA, Rickels MR, Fabbri A, Skyler JS, Alejandro R, Ricordi C. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions. Artif Organs. 2021 Sep;45(9):968-986. DOI: 10.1111/aor.14023. Epub 2021 Jul 15.

  32. Infante M, Leoni M, Caprio M, Fabbri A. Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind. World J Diabetes. 2021 Jul 15;12(7):916-931. DOI: 10.4239/wjd.v12.i7.916.

  33. Velikova T, Fabbri A, Infante M. The role of vitamin D as a potential adjuvant for COVID-19 vaccines. Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5323-5327. DOI: 10.26355/eurrev_202109_26637.

  34. Infante M, Pieri M, Lupisella S, D'Amore L, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Morello M. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5889-5903. DOI: 10.26355/eurrev_202110_26865.

  35. Rios P, Baidal D, Lemos J, Camhi SS, Infante M, Padilla N, Alvarez Gil AM, Fuenmayor V, Ambut J, Qasmi FA, Mantero AM, Cayetano SM, Ruiz P, Ricordi C, Alejandro R. Long-term Persistence of Allosensitization After Islet Allograft Failure. Transplantation. 2021 Nov 1;105(11):2490-2498. DOI: 10.1097/TP.0000000000003635.

  36. Pastore D, Deja-Simoni A, De Stefano A, Pacifici F, Cela E, Infante M, Coppola A, Di Daniele N, Lauro D, Della-Morte D, Donadel G. Risk factors for diabetic foot ulcers: an Albanian retrospective study of inpatients with type 2 diabetes. Eur Rev Med Pharmacol Sci. 2022 Jan;26(2):558-572. DOI: 10.26355/eurrev_202201_27883.

  37. Infante M, Padilla N, Alejandro R, Caprio M, Della-Morte D, Fabbri A, Ricordi C. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents. Medicina (Kaunas). 2022 Apr 21;58(5):571. DOI: 10.3390/medicina58050571.

  38. Infante M, Di Perna P, Passeri M, Monetta R, Papola F, Brancati F, Caprio M, Fabbri A. 204-LB: An Unusual Case of Autoantibody-Negative Ketosis-Prone Diabetes (KPD) Secondary to Marked Insulin Resistance. Diabetes 2022;71(Supplement_1):204-LB (June 1, 2022). DOI: 10.2337/db22-204-LB.

  39. Infante M, Fabbri A, Padilla N, Pacifici F, Di Perna P, Vitiello L, Feraco A, Giuliano M, Passeri M, Caprio M, Ricordi C, Della-Morte D, Uccioli L. BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report. Vaccines (Basel). 2022 Jul 8;10(7):1096. DOI: 10.3390/vaccines10071096. PMID: 35891261.

  40. Silvestri F*, Infante M*, Fabbri A, Ferrara C, Ferraguti G, Costantino F, Ferrari E, Bonci E, Turchetti A, Tiberti C, Tromba V. Skeletal status in children and adolescents with new-onset type 1 diabetes: a preliminary study based on bone densitometry and quantitative ultrasound. Pediatr Endocrinol Diabetes Metab. 2022 Sep 22:47551. DOI: 10.5114/pedm.2022.118317. Epub ahead of print. PMID: 36134673. *Equal contribution to the manuscript.

  41. Marzolla V, Infante M, Armani A, Rizzo M, Caprio M. Efficacy and safety of finerenone for treatment of diabetic kidney disease: current knowledge and future perspective. Expert Opin Drug Saf. 2022 Sep 29. DOI: 10.1080/14740338.2022.2130889. Epub ahead of print. PMID: 36174659.

  42. Infante M, Fabbri A, Della-Morte D, Ricordi C. The importance of vitamin D and omega-3 PUFA supplementation: a nonpharmacologic immunomodulation strategy to halt autoimmunity. Eur Rev Med Pharmacol Sci. 2022 Sep;26(18):6787-6795. DOI: 10.26355/eurrev_202209_29780. PMID: 36196727.

  43. Infante M, Ricordi C. The unique pathophysiological features of diabetes mellitus secondary to total pancreatectomy: proposal for a new classification distinct from diabetes of the exocrine pancreas. Expert Rev Endocrinol Metab. 2023 Jan;18(1):19-32. DOI: 10.1080/17446651.2023.2168645. Epub 2023 Jan 24. PMID: 36692892.

  44. Infante M, Pieri M, Lupisella S, Mohamad A, Bernardini S, Della-Morte D, Fabbri A, De Stefano A, Iannetta M, Ansaldo L, Crea A, Andreoni M, Morello M. Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19. Curr Med Res Opin. 2023 Apr;39(4):505-516. DOI: 10.1080/03007995.2023.2177380. Epub 2023 Feb 22. PMID: 36749566.

  45. D’Alessandro A, Ciavardelli D, Pastore A, Lupisella S, Cristofaro RC, Di Felice G, Salierno R, Infante M, De Stefano A, Onetti Muda A, Morello M, Porzio O. Contribution of vitamin D3 and thiols status to the outcome of COVID-19 disease in Italian pediatric and adult patients. Sci Rep. 2023 Feb 13;13(1):2504. DOI: 10.1038/s41598-023-29519-7. Erratum in: Sci Rep. 2023 Mar 16;13(1):4378. PMID: 36781931; PMCID: PMC9925220. [Author correction: D’Alessandro A, Ciavardelli D, Pastore A, Lupisella S, Cristofaro RC, Di Felice G, Salierno R, Infante M, De Stefano A, Onetti Muda A, Morello M, Porzio O. Author Correction: Contribution of vitamin D3 and thiols status to the outcome of COVID-19 disease in Italian pediatric and adult patients. Sci Rep. 2023 Mar 16;13(1):4378. DOI: 10.1038/s41598-023-31323-2. Erratum for: Sci Rep. 2023 Feb 13;13(1):2504. PMID: 36928368; PMCID: PMC10019380].

  46. Pacifici F, Malatesta G, Mammi C, Pastore D, Marzolla V, Ricordi C, Chiereghin F, Infante M, Donadel G, Curcio F, Noce A, Rovella V, Lauro D, Tesauro M, Di Daniele N, Garaci E, Caprio M, Della-Morte D. A Novel Mix of Polyphenols and Micronutrients Reduces Adipogenesis and Promotes White Adipose Tissue Browning via UCP1 Expression and AMPK Activation. Cells. 2023 Feb 24;12(5):714. DOI: 10.3390/cells12050714. PMID: 36899850.

  47. Bellucci E, Chiereghin F, Pacifici F, Donadel G, De Stefano A, Malatesta G, Valente MG, Guadagni F, Infante M, Rovella V, Noce A, Tesauro M, Di Daniele N, Della Morte D, Pastore D. Novel therapeutic approaches based on the pathological role of gut dysbiosis on the link between nonalcoholic fatty liver disease and insulin resistance. Eur Rev Med Pharmacol Sci. 2023 Mar;27(5):1921-1944. DOI: 10.26355/eurrev_202303_31558. PMID: 36930488.

  48. Pinheiro MM, Pinheiro FMM, de Arruda MM, Beato GM, Verde GACL, Bianchini G, Casalenuovo PRM, Argolo AAA, de Souza LT, Pessoa FG, Hirose TS, Senra EF, Ricordi C, Fabbri A, Infante M, Diniz SN. Association between sitagliptin plus vitamin D3 (VIDPP-4i) use and clinical remission in patients with new-onset type 1 diabetes: a retrospective case-control study. Arch Endocrinol Metab. 2023 May 25;67(5):e000652. DOI: 10.20945/2359-3997000000652. PMID: 37249465.

  49. Boccuzzi L*, Infante M*, Ricordi C. The potential therapeutic role of vitamin D in inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 2023 May;27(10):4678-4687. DOI: 10.26355/eurrev_202305_32479. PMID: 37259751. *Equal contribution to the manuscript.

  50. Della-Morte D, Ambrosi C, Chiereghin F, Infante M, Pastore D, Pacifici F, Scaramella M, Gentile L, Mulas F, Quintavalle G. Methods for inactivation of seafood Anisakis larvae and prevention of human anisakiasis: a mini-review. Eur Rev Med Pharmacol Sci. 2023 Jun;27(11):5246-5256. DOI: 10.26355/eurrev_202306_32643. PMID: 37318499.

  51. Infante M, Vitiello L, Fabbri A, Ricordi C, Padilla N, Pacifici F, Perna PD, Passeri M, Della-Morte D, Caprio M, Uccioli L. Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case report. Immunotherapy. 2023 Sep;15(13):1009-1019. DOI: 10.2217/imt-2022-0266. Epub 2023 Jul 4. PMID: 37401348.


Book Chapters:



  1. Andrea Fabbri, Marco Infante, Massimiliano Caprio. Manuale di Endocrinologia Geriatrica, SICS editore (2017). Capitolo 13 - Osteoporosi. ISBN-13: 978-8890685293.

  2. Massimiliano Caprio, Marco Infante, Andrea Fabbri. Manuale di Endocrinologia Geriatrica, SICS editore (2017). Capitolo 16 - Invecchiamento vascolare e sistema mineralcorticoide. ISBN-13: 978-8890685293. 

  3. Marco Infante, Andrea Armani, Vincenzo Marzolla, Andrea Fabbri, Massimiliano Caprio. Aldosterone, Volume 109, 1st Edition, Vitamins and Hormones series by Elsevier, Series Editor: Gerald Litwack (January 2019). Chapter 8 - Adipocyte Mineralocorticoid Receptor. DOI: 10.1016/bs.vh.2018.10.005. ISBN: 9780128177822. 

  4. Andrea Armani, Vincenzo Marzolla, Alessandra Feraco, Stefania Gorini, Caterina Mammi, Marco Infante and Massimiliano Caprio. Aldosterone-Mineralocorticoid Receptor - Cell Biology to Translational Medicine (IntechOpen, September 2019). Editors: Brian Harvey and Frederic Jaisser. Chapter 8 - Mineralocorticoid Receptor in Novel Target Tissues: A Closer Look at the Adipocyte. DOI: 10.5772/intechopen.87231. ISBN: 978-1-83962-198-7. 

  5. Marco Infante, Nathalia Padilla, Srigita Madiraju, Ana Alvarez, David Baidal, Camillo Ricordi, Rodolfo Alejandro. Combined liver and islet transplantation in hepatogenous diabetes, cluster exenteration, and cirrhosis with type 1 diabetes. Chapter 37 in: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, 1st Edition, Volume 1. San Diego: Elsevier Inc./Academic Press, 2020: 439-453. DOI: 10.1016/B978-0-12-814833-4.00037-X. ISBN: 9780128148334. 

  6. David A. Baidal, Marco Infante, Virginia Fuenmayor, Ana M. Alvarez, Nathalia Padilla, Dora M. Berman, Antonello Pileggi, Elina Linetsky, Gaetano Ciancio, Camillo Ricordi, Rodolfo Alejandro. A biologic resorbable scaffold for tissue engineering of the endocrine pancreas: Clinical experience of islet transplantation on the omentum. Chapter 19 in: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, 1st Edition, Volume 2. San Diego: Elsevier Inc./Academic Press, 2020: 269-276. DOI: 10.1016/B978-0-12-814831-0.00019-1. ISBN: 9780128148310. 

  7. Marco Infante, Massimiliano Caprio, Andrea Fabbri (2020) Introduction: Causes and Risk Factors for Male Osteoporosis. Chapter 5 in: Ferlin A., Migliaccio S. (eds) Male Osteoporosis. Trends in Andrology and Sexual Medicine. Springer, Cham. DOI: 10.1007/978-3-319-96376-1_5. ISBN: 978-3-319-96376-1. 

  8. Marco Infante, Rodolfo Alejandro, Andrea Fabbri, and Camillo Ricordi. The heterogeneity of type 1 diabetes: From immunopathology to immune intervention. Chapter 5 in: Translational Autoimmunity (Elsevier), 1st Edition, Volume 4 (Autoimmune Diseases in Different Organs), May 1, 2022 (Editor: Nima Rezaei). DOI: 10.1016/B978-0-12-824466-1.00001-7. ISBN: 9780128244661.

  9. Marco Infante. The Insulin Journey in the Human Body. Chapter 1 in: Evolving Concepts in Insulin Resistance (IntechOpen), December 7, 2022 (Academic Editor: Marco Infante). DOI: 10.5772/intechopen.107906. ISBN: 9781803555027. PRINT ISBN: 9781803555010.

  10. Martina Leoni, Nathalia Padilla, Andrea Fabbri, David Della-Morte, Camillo Ricordi and Marco Infante. Mechanisms of Insulin Resistance during Pregnancy. Chapter 4 in: Evolving Concepts in Insulin Resistance (IntechOpen), December 7, 2022 (Academic Editor: Marco Infante). DOI: 10.5772/intechopen.107907. ISBN: 9781803555027. PRINT ISBN: 9781803555010.


Edited Books:



  1. Evolving Concepts in Insulin Resistance (IntechOpen), December 7, 2022 (Academic Editor: Marco Infante). ISBN: 9781803555027. PRINT ISBN: 9781803555010. EBOOK (PDF): ISBN 9781803555034.


Technical Reports:



  1. Marco Infante, Andrea Fabbri, Camillo Ricordi. Towards a sustainable prevention of type 2 diabetes. Europe and Food Report 2021, Barilla Center for Food & Nutrition Foundation (BCFN, May 2021, pp. 44-47; URL: www.fondazionebarilla.com/wp-content/uploads/2021/02/europe-and-food.pdf).


Articles and Commentaries in peer-reviewed Italian Journals:



  1. Caprio M, Infante M, Armani A, Lenzi A, Fabbri A. Recettore mineralcorticoide e organo adiposo: implicazioni cliniche e terapeutiche. L'Endocrinologo (2016) 17:73. DOI: 10.1007/s40619-016-0179-9.

  2. Fabbri A, Infante M, Petrelli M, Arnaldi G.  Anoressia nervosa e salute dell'osso. L'Endocrinologo (2017) 18: 2. DOI: 10.1007/s40619-017-0262-x.

  3. Infante M, Fabbri A. Effetti della co-supplementazione di vitamina D e acidi grassi omega-3 sul controllo glicemico e le concentrazioni lipidiche nelle pazienti affette da diabete mellito gestazionale. L'Endocrinologo (2017) 18:197. DOI: 10.1007/s40619-017-0335-x.

  4. Infante M, Fabbri A. Le cellule iNKT inducono l'espressione di FGF21 per la termogenesi e sono essenziali per ottenere la massima perdita di peso in corso di trattamento con analoghi del GLP-1. L'Endocrinologo (2017) 18: 308. DOI: 10.1007/s40619-017-0370-7.

  5. Infante M, Fabbri A. Gli acidi grassi polinsaturi omega-3 migliorano il diabete di tipo 1 e l’autoimmunità. L'Endocrinologo (2018) 19:114. DOI: 10.1007/s40619-018-0427-2.

  6. Infante M, Fabbri A. Concentrazioni plasmatiche di 25-idrossivitamina D e rischio di diabete di tipo 2 e pre-diabete: uno studio di coorte di 12 anni. L'Endocrinologo (2018) 19:223. DOI: 10.1007/s40619-018-0461-0.

  7. Infante M, Fabbri A. La liraglutide aumenta i tassi di gravidanza dopo IVF in donne obese con PCOS e scarsa risposta alle terapie di prima linea: uno studio pilota randomizzato. L'Endocrinologo (2018) 19:331. DOI: 10.1007/s40619-018-00503-y.

  8. Infante M, Fabbri A. Supplementazione di vitamina D e prevenzione di cancro e malattie cardiovascolari. L'Endocrinologo (2019) 20:113. DOI: 10.1007/s40619-019-00566-5.

  9. Moriconi E, Infante M, Gorini S, Fabbri A, Caprio M. Come avviare il paziente obeso alla terapia chetogenica. L’Endocrinologo (2019) 20:196. DOI: 10.1007/s40619-019-00602-4.

  10. Infante M, Fabbri A. Supplementazione di vitamina D e prevenzione del diabete di tipo 2. L'Endocrinologo (2019) 20:250. DOI: 10.1007/s40619-019-00610-4.

  11. Infante M, Di Perna P, Fabbri A. Risultati a 10 anni del trapianto di isole pancreatiche isolato o dopo trapianto renale nel diabete di tipo 1: uno studio di coorte prospettico a gruppi paralleli. L'Endocrinologo 21, 60–61 (2020). DOI: 10.1007/s40619-020-00664-9.

  12. Infante M, Fabbri A. Impatto della sequenza temporale di ingestione degli alimenti sulle escursioni glicemiche post-prandiali nel prediabete. L'Endocrinologo 21, 68–69 (2020). DOI: 10.1007/s40619-020-00662-x.

  13. Infante M, Velikova T, Fabbri A. Vitamin D and anti-COVID-19 vaccination. LRIOG - La Rivista Italiana di Ostetrica e Ginecologia. Volume 2021, Issue 4 (December 1, 2021): 51-59. p-ISSN: 1724-6776. e-ISSN: 1824-0283. DOI: 10.53146/lriog1202148.

  14. Leoni M*, Infante M*, Infante R, Caprio M, Fabbri A. Hypovitaminosis D and metabolic syndrome. LRIOG - La Rivista Italiana di Ostetrica e Ginecologia. Volume 2022, Issue 1 (March 1, 2022): 95-106. p-ISSN: 1724-6776. e-ISSN: 1824-0283. DOI: 10.53146/lriog1202162. *Equal contribution to the manuscript.


Member of the Editorial Board in the following peer-reviewed international Journals:



  • Managing Editor- CellR4; from January 2020 to present

  • Associate Editor - Frontiers in Clinical Diabetes and Healthcare - Specialty section "Diabetes Geographic Inequalities"; from December 2020 to present

  • Academic Editor - Journal of Diabetes Research (Hindawi publisher); from November 2021 to present

  • Review Editor - "Autoimmune and Autoinflammatory Disorders" specialty section of Frontiers in Immunology; from May 2020 to present

  • Review Editor - "Clinical Diabetes" specialty section of Frontiers in Public Health and Frontiers in Endocrinology; from April 2020 to present

  • Review Editor - "Obesity" specialty section of Frontiers in Public Health and Frontiers in Endocrinology; from February 2020 to present

  • Reviewer Board Member - Nutrients (MDPI publisher); from October 2020 to present

  • Editorial Board Member - European Review for Medical and Pharmacological Sciences (Verduci Editore); from July 2021 to present

  • ­Editorial Board Member - World Journal of Clinical Cases (Baishideng Publishing Group); from January 2022 to present

  • Topic Editor - Applied Sciences (MDPI publisher); from February 2021 to August 2021


Ad Hoc Reviewer for the following peer-reviewed international Journals:



  • Frontiers in Endocrinology

  • Frontiers in Clinical Diabetes and Healthcare

  • Endocrinology, Diabetes & Metabolism (Wiley)

  • Journal of Diabetes and its Complications

  • Journal of Diabetes Investigation (Wiley)

  • Frontiers in Immunology

  • BMJ Open

  • iScience (Cell Press)

  • eBioMedicine (The Lancet Group)

  • Journal of Diabetes (Wiley)

  • Diabetic Medicine (Wiley)

  • Canadian Journal of Diabetes (CJD)

  • BMC Endocrine Disorders

  • Frontiers in Public Health

  • International Journal of Molecular Sciences

  • Journal of Diabetes Research (Hindawi publisher)

  • Journal of Clinical Medicine

  • Journal of the American College of Nutrition

  • Nutrients

  • Healthcare

  • BioMed Research International

  • European Journal of Clinical Pharmacology

  • European Review for Medical and Pharmacological Sciences

  • World Journal of Diabetes

  • World Journal of Clinical Cases

  • SAGE Open Medicine

  • Biomarkers in Medicine

  • Biology (MDPI)

  • Vaccines (MDPI)

  • Medical Science Monitor


Honors and Awards:



  • August 9, 2023 – Full Member Induction into the Sigma Xi Scientific Research Honor Society, the world’s largest interdisciplinary scientific honor society founded in 1886 at Cornell University (Ithaca, NY, USA).

  • May, 2022 – Medicina (MDPI) Issue Cover (Volume 58, Issue 5, May 2022) dedicated to the article entitled “Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents” by Marco Infante, Nathalia Padilla, Rodolfo Alejandro, Massimiliano Caprio, David Della Morte, Andrea Fabbri and Camillo Ricordi.

  • April 21, 2021 - Designation as Fellow of the American College of Nutrition (FACN) for the research activity in the field of Immunomodulatory Nutrition.

  • September, 2021 – Artificial Organs (Wiley) Issue Cover (Volume 45, Issue 9, September 2021) dedicated to the article entitled “Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions” by Marco Infante, David A. Baidal, Michael R. Rickels, Andrea Fabbri, Jay S. Skyler, Rodolfo Alejandro and Camillo Ricordi.

  • 2019/2020 - Bentham Science Ambassador for Bentham Science Publisher.

  • March, 2017 – Travel Grant Award by “Aldosterone and Mineralocorticoid Receptor (ADMIRE) COST ACTION”. ADMIRE Annual Scientific Meeting, Royal College of Surgeons in Ireland, March 2-3, 2017, Dublin (Ireland).

  • June 2015 – Travel Grant Award by “Aldosterone and Mineralocorticoid Receptor (ADMIRE) COST Action” and “Investigation Network Initiative - Cardiovascular and Renal Clinical Trialists (INI-CRCT)”. Clinical Research Training Workshop on Randomized Controlled Trials, Cordelier Research Center, June 22, 2015, Paris (France).


Acknowledgements:



  • Nutrients Editorial Office. Acknowledgement to Reviewers of Nutrients in 2019. Nutrients. 2020;12(1):273. Published 2020 Jan 20. DOI:10.3390/nu12010273.

  • International Journal of Molecular Sciences Editorial Office. Acknowledgment to Reviewers of the International Journal of Molecular Sciences in 2020. Int J Mol Sci. 2021;22(3):1123. Published 2021 Jan 23. DOI:10.3390/ijms22031123.

  • Nutrients Editorial Office. Acknowledgment to Reviewers of Nutrients in 2020. Nutrients. 2021;13(2):382. Published 2021 Jan 26. DOI:10.3390/nu13020382.

  • Journal of Clinical Medicine Editorial Office. Acknowledgment to Reviewers of Journal of Clinical Medicine in 2020. J Clin Med. 2021;10(4):865. Published 2021 Feb 19. DOI:10.3390/jcm10040865.

  • Biology Editorial Office. Acknowledgment to Reviewers of Biology in 2021. Biology 2022, 11(2), 226. Published 30 January 2022. DOI: 10.3390/biology11020226.

  • International Journal of Molecular Sciences Editorial Office. Acknowledgment to Reviewers of IJMS in 2021. Int. J. Mol. Sci. 2022, 23(3), 1628. Published 31 January 2022. DOI: 10.3390/ijms23031628.

  • Nutrients Editorial Office. Acknowledgment to Reviewers of Nutrients in 2021. Nutrients 2022, 14(5), 940. Published 23 February 2022. DOI: 10.3390/nu14050940.

  • Wiley Top Cited Article 2020-2021 Acknowledgement for “Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic” published in Journal of Diabetes (J Diabetes. 2020 Sep;12(9):659-667. DOI: 10.1111/1753-0407.13053).

  • Vaccines Editorial Office. Acknowledgment to the Reviewers of Vaccines in 2022. Vaccines 2023, 11(2), 227. Published 19 January 2023. DOI: 10.3390/vaccines11020227.


 


Additional information:



 

No items yet!

Your experience on this site will be improved by allowing cookies.